Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / MED BREAKTHGH
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
2,142,561
-
Shares change
-
+396,561
-
Total reported value, excl. options
-
$84,351,772
-
Value change
-
+$15,619,448
-
Put/Call ratio
-
97.9%
-
Number of buys
-
38
-
Number of sells
-
-14
-
Price
-
$39.37
Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q3 2018
65 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q3 2018.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,142,561 shares
.
Largest 10 shareholders include UBS Group AG (447,226 shares), BANK OF AMERICA CORP /DE/ (421,667 shares), MORGAN STANLEY (274,220 shares), RAYMOND JAMES & ASSOCIATES (168,246 shares), WELLS FARGO & COMPANY/MN (152,284 shares), BAROMETER CAPITAL MANAGEMENT INC. (102,100 shares), JANE STREET GROUP, LLC (80,644 shares), NTV Asset Management LLC (54,448 shares), Cavalier Investments, LLC (51,892 shares), and LPL Financial LLC (41,569 shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.